Patients Understanding their Cancer and Treatment Options
Gary Palmer, MD
Video Categories: Targeted Therapies
In this next segment, Dr Agarwala discusses when and how molecular tests should be utilized.
Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.